Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IMNN | IMUNON INC | $12.39M | $5.65 | $232.50 | 4,015.04% | Strong Buy | 2 | N/A | N/A | -247.15% | -74.80% | |||
| ACXP | ACURX PHARMACEUTICALS INC | $6.77M | $4.27 | $143.67 | 3,264.57% | Buy | 3 | N/A | N/A | -1,395.33% | -808.10% | |||
| FBLG | FIBROBIOLOGICS INC | $23.67M | $0.57 | $14.00 | 2,377.88% | Strong Buy | 2 | N/A | N/A | -5,552.75% | -343.38% | |||
| FEMY | FEMASYS INC | $10.00M | $0.37 | $7.00 | 1,807.36% | Strong Buy | 2 | 157.73% | N/A | -395.63% | -59.49% | |||
| MRSN | MERSANA THERAPEUTICS INC | $37.28M | $7.47 | $140.00 | 1,774.16% | Strong Buy | 2 | 12.06% | N/A | N/A | -12.89% | |||
| UNCY | UNICYCIVE THERAPEUTICS INC | $72.24M | $4.09 | $75.00 | 1,733.74% | Strong Buy | 3 | N/A | N/A | 796.95% | 436.51% | |||
| PSTV | PLUS THERAPEUTICS INC | $46.65M | $0.47 | $7.88 | 1,575.53% | Strong Buy | 4 | 41.35% | N/A | 359.89% | 105.50% | |||
| REE | REE AUTOMOTIVE LTD | $16.07M | $0.72 | $11.75 | 1,527.42% | Strong Buy | 2 | 1,231.58% | N/A | N/A | N/A | |||
| CODX | CO-DIAGNOSTICS INC | $13.25M | $0.34 | $5.50 | 1,498.84% | Buy | 2 | -19.29% | N/A | -36.52% | -32.33% | |||
| CBUS | CIBUS INC | $75.93M | $1.40 | $21.25 | 1,417.86% | Strong Buy | 2 | 71.40% | N/A | -1.50% | -0.31% | |||
| CLSD | CLEARSIDE BIOMEDICAL INC | $27.20M | $0.35 | $4.75 | 1,257.14% | Buy | 4 | 112.27% | N/A | N/A | -43.46% | |||
| MBRX | MOLECULIN BIOTECH INC | $11.39M | $0.38 | $5.00 | 1,229.79% | Strong Buy | 4 | N/A | N/A | N/A | -67.32% | |||
| MTVA | METAVIA INC | $16.55M | $0.68 | $9.00 | 1,215.79% | Strong Buy | 3 | N/A | N/A | -279.09% | -145.51% | |||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $29.06M | $0.51 | $6.50 | 1,187.13% | Buy | 2 | 299.93% | N/A | N/A | -188.43% | |||
| SGMO | SANGAMO THERAPEUTICS INC | $160.51M | $0.53 | $6.75 | 1,168.80% | Buy | 4 | 8.11% | N/A | 92.35% | 18.56% | |||
| GOVX | GEOVAX LABS INC | $18.18M | $0.72 | $8.50 | 1,085.50% | Strong Buy | 2 | N/A | N/A | 4,539.42% | 2,393.57% | |||
| FGEN | FIBROGEN INC | $50.27M | $12.43 | $146.50 | 1,078.60% | Buy | 2 | N/A | N/A | N/A | -19.10% | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $49.35M | $3.39 | $38.00 | 1,020.94% | Strong Buy | 2 | 405.49% | N/A | N/A | N/A | |||
| NRXP | NRX PHARMACEUTICALS INC | $56.75M | $2.88 | $31.40 | 990.28% | Strong Buy | 5 | N/A | N/A | -276.64% | 2,036.49% | |||
| GRI | GRI BIO INC | $5.16M | $2.05 | $22.00 | 973.17% | Buy | 2 | N/A | N/A | -26.50% | -15.51% | |||
| LSTA | LISATA THERAPEUTICS INC | $19.26M | $2.24 | $23.50 | 949.11% | Strong Buy | 2 | 240.34% | N/A | -33.23% | -29.08% | |||
| MDCX | MEDICUS PHARMA LTD | $40.09M | $2.25 | $23.50 | 944.44% | Strong Buy | 2 | N/A | N/A | -82.26% | -22.39% | |||
| XFOR | X4 PHARMACEUTICALS INC | $19.10M | $3.30 | $34.17 | 935.36% | Strong Buy | 3 | 47.69% | -39.35% | -8.07% | -1.42% | |||
| PMN | PROMIS NEUROSCIENCES INC | $21.76M | $0.42 | $4.33 | 931.67% | Strong Buy | 3 | N/A | N/A | -2,302.04% | 92.61% | |||
| IMUX | IMMUNIC INC | $81.64M | $0.85 | $8.33 | 878.05% | Strong Buy | 3 | N/A | N/A | N/A | -182.15% | |||
| INTS | INTENSITY THERAPEUTICS INC | $10.92M | $0.23 | $2.25 | 869.83% | Strong Buy | 2 | N/A | N/A | -517.12% | -254.19% | |||
| BOLT | BOLT BIOTHERAPEUTICS INC | $10.12M | $5.27 | $50.00 | 848.77% | Buy | 2 | N/A | N/A | N/A | N/A | |||
| ACRV | ACRIVON THERAPEUTICS INC | $48.76M | $1.55 | $14.67 | 846.26% | Buy | 3 | N/A | N/A | -37.06% | -33.42% | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $25.53M | $1.07 | $10.00 | 834.58% | Strong Buy | 2 | N/A | N/A | -71.37% | -60.18% | |||
| CING | CINGULATE INC | $21.27M | $3.93 | $36.50 | 828.75% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| JSPR | JASPER THERAPEUTICS INC | $41.61M | $2.56 | $23.71 | 826.33% | Buy | 7 | N/A | N/A | -387.30% | -195.88% | |||
| MYO | MYOMO INC | $33.98M | $0.90 | $8.17 | 808.45% | Buy | 3 | N/A | N/A | N/A | N/A | |||
| CRIS | CURIS INC | $22.75M | $1.82 | $16.50 | 806.59% | Buy | 2 | 41.98% | N/A | -51.83% | 24.80% | |||
| EKSO | EKSO BIONICS HOLDINGS INC | $10.24M | $3.92 | $34.75 | 786.48% | Strong Buy | 2 | 17.65% | N/A | -2.15% | -1.01% | |||
| CYBN | CYBIN INC | $138.43M | $6.01 | $52.50 | 773.54% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| PASG | PASSAGE BIO INC | $22.16M | $6.97 | $59.25 | 750.07% | Strong Buy | 4 | N/A | N/A | -8.89% | -4.29% | |||
| OSTX | OS THERAPIES INC | $73.67M | $2.31 | $19.50 | 744.16% | Strong Buy | 2 | N/A | N/A | 90.32% | 43.30% | |||
| CRDL | CARDIOL THERAPEUTICS INC | $88.46M | $1.07 | $9.00 | 741.12% | Buy | 2 | N/A | N/A | 158.27% | 93.74% | |||
| CERO | CERO THERAPEUTICS HOLDINGS INC | $6.63M | $5.50 | $45.00 | 718.18% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| LGVN | LONGEVERON INC | $12.07M | $0.80 | $6.50 | 717.61% | Strong Buy | 2 | 74.74% | N/A | N/A | N/A | |||
| AMTX | AEMETIS INC | $136.60M | $2.16 | $17.00 | 687.04% | Strong Buy | 3 | 61.24% | N/A | -56.63% | 68.24% | |||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $11.79M | $9.35 | $72.50 | 675.40% | Buy | 4 | N/A | N/A | N/A | N/A | |||
| CABA | CABALETTA BIO INC | $91.85M | $1.81 | $13.71 | 657.68% | Strong Buy | 7 | N/A | N/A | -84.95% | -62.53% | |||
| ATOS | ATOSSA THERAPEUTICS INC | $106.31M | $0.82 | $6.17 | 649.33% | Buy | 3 | N/A | N/A | -51.49% | -46.05% | |||
| IPSC | CENTURY THERAPEUTICS INC | $44.75M | $0.52 | $3.75 | 623.94% | Strong Buy | 4 | N/A | N/A | -40.33% | -29.74% | |||
| ALLO | ALLOGENE THERAPEUTICS INC | $259.60M | $1.17 | $8.44 | 621.71% | Strong Buy | 9 | N/A | N/A | -46.15% | -33.79% | |||
| HUMA | HUMACYTE INC | $237.56M | $1.50 | $10.67 | 611.13% | Strong Buy | 6 | 355.34% | N/A | 39.08% | 1.14% | |||
| SLN | SILENCE THERAPEUTICS PLC | $230.27M | $4.88 | $34.50 | 606.97% | Buy | 4 | 8.38% | N/A | N/A | -57.46% | |||
| CNTX | CONTEXT THERAPEUTICS INC | $74.99M | $0.84 | $5.67 | 577.87% | Strong Buy | 3 | N/A | N/A | -63.76% | -60.39% | |||
| ARTV | ARTIVA BIOTHERAPEUTICS INC | $64.97M | $2.66 | $17.60 | 561.65% | Buy | 5 | N/A | N/A | -33.51% | -29.49% | |||
| OCGN | OCUGEN INC | $312.77M | $1.07 | $7.00 | 554.21% | Strong Buy | 2 | 147.36% | N/A | 2,298.60% | 130.90% | |||
| NKTX | NKARTA INC | $147.02M | $2.07 | $13.50 | 552.17% | Strong Buy | 4 | N/A | N/A | -26.94% | -21.49% | |||
| FBRX | FORTE BIOSCIENCES INC | $130.05M | $10.46 | $68.00 | 550.10% | Strong Buy | 2 | N/A | N/A | -23.32% | -21.34% | |||
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $65.89M | $3.14 | $19.75 | 528.98% | Buy | 4 | -4.96% | N/A | N/A | -65.24% | |||
| ACET | ADICET BIO INC | $72.95M | $0.88 | $5.50 | 523.58% | Strong Buy | 2 | N/A | N/A | -47.64% | -40.22% | |||
| SNTI | SENTI BIOSCIENCES INC | $35.99M | $1.38 | $8.50 | 515.94% | Strong Buy | 2 | N/A | N/A | -55.11% | -25.21% | |||
| RNXT | RENOVORX INC | $45.44M | $1.24 | $7.50 | 504.84% | Buy | 2 | 222.30% | N/A | 92.98% | 72.52% | |||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $30.13M | $0.44 | $2.67 | 502.03% | Strong Buy | 3 | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.